Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib & Trastuzumab for Previously Treated HER2+ Metastatic Biliary Tract Cancer (SGNTUC-019)"

119 views
June 15, 2023
Comments 0
Login to view comments. Click here to Login